过去一年中添加的文章，按日期排序
The Impact of Hematologic Parameters on Histopathologic Features of Colorectal Cancer
Ö Dere, Y Dere - International Journal of General Medicine, 2024 - Taylor & Francis
85 天前 - … assess platelet (PLT) levels, along with NLR, PLR, and LCR, as inflammatory
response … individuals who had undergone neoadjuvant chemotherapy. Furthermore, numerous …
response … individuals who had undergone neoadjuvant chemotherapy. Furthermore, numerous …
… responses, gill histopathology and SEM analysis in common carp (Cyprinus carpio) exposed to varied doses of chloramine-T: A potent chemotherapeutic agent
129 天前 - … Chloramine-T (Cl-T) is a chemo-therapeutant used at … ) is a widely used
chemotherapeutic agent for the treatment of … to access pathophysiological responses in common …
chemotherapeutic agent for the treatment of … to access pathophysiological responses in common …
Full Blood Count and Cancer Antigen 15.3 Levels of Breast Cancer Subjects in Umuahia, Abia State, Nigeria
K Nnenna, KE Stella Urekweru… - … Journal of Research …, 2024 - ebooks.netkumar1.in
154 天前 - … are either not responding to the chemotherapy regimen or are not consistent to their
… chemo, healthy cells are destroyed along side the diseased ones. Mean platelet volume …
… chemo, healthy cells are destroyed along side the diseased ones. Mean platelet volume …
Pegylated nanoliposomal cisplatin ameliorates chemotherapy-induced peripheral neuropathy
M Moetamani-Ahmadi, AM Ahmadzadeh… - International Journal of …, 2024 - Elsevier
192 天前 - … -chemotherapy patients during the first month in a way that the pain still remains in
approximately 30 % of them 6 months after chemotherapy. … Responses were monitored for 1 …
approximately 30 % of them 6 months after chemotherapy. … Responses were monitored for 1 …
[HTML][HTML] NEWS/EVENT
SG Docimo - dit.edu.ng
204 天前 - … a complete response to chemotherapy. A the routine use of adjuvant chemotherapy
… A the routine use of neoadjuvant or adjuvant chemotherapy in combination with surgery …
… A the routine use of neoadjuvant or adjuvant chemotherapy in combination with surgery …
A Phase 1 Study of RJMty19: Anti-CD19 Humanized CAR-Engineered Allogeneic Double Negative T Cells in Adults with B-Cell Non-Hodgkin's Lymphoma
X Xiao, W Lei, H Jiang, X Qiu, X Li, P Chen, Y Xu, H Xie… - Blood, 2023 - Elsevier
248 天前 - … All patients received lymphodepleting chemotherapy with fludarabine and
cyclophosphamide. The primary endpoint is dose-limiting toxicities, incidence of adverse events and …
cyclophosphamide. The primary endpoint is dose-limiting toxicities, incidence of adverse events and …
18F-AlF-NOTA-FAPI-04 PET/CT can Predict Treatment Response and Survival in Patients with Inoperable Pancreatic Adenocarcinoma
Z Zhu, X Zhang, Y Zhang, X Hu, J Yue - International Journal of …, 2023 - redjournal.org
307 天前 - … chemotherapy in SUV max , MTV, and TLF were associated with good treatment
response … than ΔCA19-9 for predicting treatment response. Kaplan-Meier analysis showed that …
response … than ΔCA19-9 for predicting treatment response. Kaplan-Meier analysis showed that …